Lotus Health Group Co.

Lotus Health Group Co. saw a notable increase in stock performance on March 24, 2026, reaching an intraday high. The company has demonstrated resilience with positive metrics over various time frames, including a year-to-date performance of 13.21%. It maintains a strong return on equity and operational efficiency.

Lotus Health Group Co. faced a significant stock price decline today, reaching an intraday low. Over the past year, the company has underperformed compared to the Shanghai Composite, despite a positive year-to-date performance. Key financial metrics reveal high valuation and potential inefficiencies in inventory management.

Lotus Health Group Co. saw a notable stock price increase on March 19, 2026, reaching an intraday high amid a declining broader market. The company has demonstrated strong performance metrics over various time frames, although it faces challenges related to valuation and recent market underperformance.

Lotus Health Group Co. faced a notable decline in its stock today, contrasting with the broader market's performance. Over the past week and month, the company has seen decreases, while its annual performance lags behind the market. Despite a significant profit increase, its long-term growth remains impressive.

Lotus Health Group Co. has experienced notable stock activity, rising significantly today while the broader market declined. Year-to-date, the stock has outperformed the China Shanghai Composite, despite a one-year decline. The company, in the FMCG sector, has a market capitalization of CNY 11,401 million and strong profit growth.

Lotus Health Group Co. saw a notable increase in stock performance today, contrasting with the broader market. Despite a decline over the past week and year, the company has shown significant growth over three and five years. Financial metrics indicate a solid profitability level, though valuation appears elevated.

Lotus Health Group Co. faced a notable stock decline today, reaching an intraday low. Over the past week and month, the stock has shown significant decreases. Despite a substantial profit increase, the company has underperformed the broader market, with negative annual returns and a high price-to-book ratio indicating potential valuation concerns.

Lotus Health Group Co. saw its stock decline today, contrasting with the broader market's performance. Despite recent gains and strong operational metrics, including a significant profit increase and robust cash flow, the company has struggled over the past year, underperforming compared to the China Shanghai Composite.